At the moment, there is no specific treatment for COVID-19, such as antivirals. There have been anecdotal reports on the use of these agents; however, its efficacy and safety are yet to be determined. The implementation of timely, effective, and safe supportive therapies (oxygen, antibiotics, hydration & fever/pain relief) is the cornerstone of therapy for patients that develop severe manifestations of COVID-19.

The documents listed in this page provide minimum standards and technical description and specifications of medical devices for supportive treatment of COVID-19. These medical devices are not limited, and to be adaptable to all countries in the region irrespective of their different health care systems and socioeconomic disparities. In addition, they are recommended for Early supportive therapy and monitoring of severe acute respiratory illness (SARI) when COVID-19 infection is suspected; and Management of hypoxemic respiratory failure and Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients; o Management of septic shock in COVID-19 patients.

Guidelines related to required drugs and commodities

References:

PAHO [https://iris.paho.org/handle/10665.2/51979]

WHO